乳腺癌患者注射紫杉醇会影响月经吗?

2021-07-07 MedSci原创 MedSci原创

乳腺癌患者注射紫杉醇会影响月经吗?

《梅斯直播课:3天乳腺癌诊疗训练营》
06.25-年轻乳腺癌的治疗要点及生育管理
回答问题8:患者是第六次化疗,打了紫杉醇,月经推后了一星期了,请问,打了紫杉醇会影响月经吗?

 

欢迎点赞、评论、分享

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-09 医鸣惊人

    认真学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-09 luwei00
  3. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 机智哈

    学习一下

    0

相关资讯

年轻乳腺癌的肿瘤特征是什么?复发风险和预后有何特点?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

BRCA1/2突变的年轻患者是否适宜保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

阳性且有转移的乳腺癌患者是只能注射靶向药治疗吗?

《梅斯直播课:3天乳腺癌诊疗训练营》 06.25-年轻乳腺癌的治疗要点及生育管理 回答问题6:阳性且有转移的治疗是只能一直打靶向药么?

年轻乳腺癌ofs+AI后仍未绝经,后续如何进行内分泌治疗?

年轻乳腺癌ofs+AI后仍未绝经,后续如何内分泌治疗?

年轻乳腺癌应选择乳房切除术还是保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

拓展阅读

长春工业大学郑敏教授/中科院应化所谢志刚研究员团队AFM:递送紫杉醇和IDO抑制剂的自载体纳米颗粒,用于促进抗肿瘤化疗-免疫治疗

这项工作提供了一种简便的方法来递送化疗和免疫调剂药物,以实现化疗增强的免疫治疗。

BJS:在胰腺癌和腹膜转移患者中添加腹腔内紫杉醇疗效

本I/II期研究的目的是确定静脉注射纳曲奇利他/吉西他滨和腹腔内紫杉醇在胰腺癌和腹膜转移患者中联合使用的推荐剂量,并评估其临床疗效和安全性。

Lancet Oncol:3期OUTBACK临床爆阴!局晚期宫颈癌放化疗后的辅助化疗并无生存获益,甚至毒性更大...

这项3期临床研究结果提示,在标准的以顺铂为基础的局部晚期宫颈癌放化疗后给予辅助卡铂和紫杉醇化疗增加了短期毒性,并没有提高总生存期。

Clin Cancer Res:紫杉醇加用Napabucasin治疗晚期胃/胃食管交界腺癌的疗效

紫杉醇加用Napabucasin并不能改善预处理的晚期胃腺癌或GEJ腺癌患者的生存预后

Breast Cancer Res Treat:局部亚微米颗粒紫杉醇可有效治疗乳腺癌皮肤转移

乳腺癌患者的皮肤转移并不少见,发病率在5%至10%之间。近日,一项1/2期研究评估了无水软膏基质的局部亚微米颗粒紫杉醇(SPP)治疗发生皮肤转移的效果。

Lancet Oncol:每周用药的剂量密集性化疗在卵巢癌中的疗效和安全性

与标准的3周化疗方案相比,每周给药的密集化疗方案并未改善上皮性卵巢癌患者的总体或无进展生存期